American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility
American Well Corporation (NYSE:AMWL ) Q1 2024 Earnings Call Transcript May 1, 2024 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Robert Shepardson - Chief Financial Officer Conference Call Participants Charles Rhyee - TD Cowen Craig Hettenbach - Morgan Stanley Jessica Tassan - Piper Sandler Jailendra Singh - Truist Securities Matthew Shea - Needham & Company Stan Berenshteyn - Wells Fargo Securities Hanna Lee - Bank of America Jenny Shen - BTIG Jack Wallace - Guggenheim Securities Operator Good afternoon. My name is Briana, and I will be your conference operator today.
Although the revenue and EPS for American Well (AMWL) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
American Well Corporation (AMWL) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.24 per share a year ago.
Boston, April 17, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, will report its first quarter 2024 operating results Wednesday, May 1.
Boston, April 04, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of healthcare software as a service, today announced that it received a notice on April 2, 2024 from the New York Stock Exchange (NYSE) informing the company that it is not in compliance with the NYSE's continued listing minimum price criteria with respect to its Class A common stock because the average closing price of the company's Class A common stock was less than $1 per share over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the company's Class A common stock from the NYSE.
Horner brings to the role 25 years in family medicine, completion of 25,000 virtual care visits Horner brings to the role 25 years in family medicine, completion of 25,000 virtual care visits
Boston, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, announced that company executives will participate in the TD Cowen Health Care Conference on Tuesday, March 5 in Boston.
The headline numbers for American Well Corporation (AMWL) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.